#USA #Austin #oncology #ASCO #Jiro Health

Jiro Health Partners with ASCO

In an innovative leap forward in oncology, Jiro Health announced a substantive multi-year agreement with Wolters Kluwer Health, the publisher behind the American Society of Clinical Oncology (ASCO) journals. This collaboration seeks to transform how oncologists engage with clinical evidence, personalizing their access to crucial medical insights tailored to their specific patient populations.

Oncology is an ever-evolving field, with rapid advancements in treatment options and clinical methodologies. These changes demand that clinicians continuously update their knowledge with the latest therapeutic developments and clinical guidelines. Jiro aims to bridge the gap between extensive clinical research and everyday clinical practice through its Practice Intelligence platform.

Under the new agreement, Jiro will integrate valuable content from ASCO’s journals into its platform, presenting oncologists with pertinent data that resonates with their clinical activities. Instead of merely providing access to vast amounts of information buried behind complex search functions, Jiro delivers actionable insights directly tied to the specific patient profiles that clinicians are handling. This represents a significant shift from traditional models of information retrieval, moving towards more proactive, personalized support.

“ASCO represents the gold standard in oncology. Too often, knowledge remains hidden behind search bars,” explained Greg Field, Co-Founder and CEO of Jiro. “Our approach ensures that the best practices derived from ASCO’s content emerge in real-time, addressing clinicians' needs just when they're most necessary.”

How It Works

The service operates through two primary features: Discover and Consult.

1. Discover: This tool automatically identifies and presents relevant content from the JCO journals, including research on clinical trials, emerging therapies, and important editorial insights tailored specifically to each clinician's patient demographic. For instance, an oncologist treating HER2-positive breast cancer will receive alerts regarding the latest research on cardiac monitoring intervals and updated commentary on treatment dosing—before making critical decisions about patient care.

2. Consult: This feature allows clinicians to harness ASCO guidelines while considering real-world data from their own patient experiences. Engaging with this aspect, an oncologist can input a clinical scenario and receive a well-rounded answer integrating peer-reviewed literature alongside practical, evidence-based insights derived from similar cases they have faced in their practice. This synergy of guideline adherence and practical experience leads to improved care pathways for patients.

The Bigger Picture for Oncology

The rise of real-world evidence (RWE) is reshaping how healthcare providers approach patient management, especially in high-stakes fields like oncology with ever-changing treatment landscapes. With innovative agents and shifting standards of care challenging clinicians, the ability to conveniently access and interpret relevant data will soon become the cornerstone of patient care.

Shaji Kumar, an esteemed hematologist and member of Jiro's advisory board, asserted, “In hematology, change occurs relentlessly with new agents and evolving therapeutic standards. The influx of information isn’t just a matter of staying informed; it’s a challenge of managing the volume of new findings while working with diverse patient cases.” Utilizing Jiro's newly integrated ASCO content, the right evidence reaches practitioners in a timely manner and is relevant to the patients they serve.

Conclusion

The partnership between Jiro Health and ASCO marks a substantial progression in the intersection of digital health solutions and oncology practices. As it continues to pioneer personalized, actionable AI solutions for clinicians, Jiro Health is set to enhance clinical decision-making at the very frontline of cancer care. For verified clinicians within the United States keen on utilizing this advanced resource, the platform is readily available via www.jirohealth.com and is free to use. By integrating high-quality evidence into daily practice, medical professionals can navigate the complexities of oncology with greater confidence and insight.

For more information on Jiro Health and its innovative solutions, please visit www.jirohealth.com.